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Objective: To provide up-to-date population-based data on nationwide trends in pneumonia
hospitalization rates and associated 30-day mortality.
Methods: Using medical databases we identified all in-hospital episodes of pneumonia between
1997 and 2011. We computed age- and sex-standardized hospitalization rates of total and first-
time pneumonia-related hospitalization and adjusted 30-day mortality rates by calendar year.
Results: Among 552,528 pneumonia-related hospitalizations in Denmark between 1997 and
2011, 385,985 (69.9%) were first-time events. Total pneumonia hospitalizations increased by
63%, from 4.96 per 1000 population in 1997 to 8.09 in 2011. Rates of first-time pneumonia per
1000 population increased by 33%, from 3.99 in 1997 to 5.31 in 2011. Pneumonia rates stabilized
in the mid-00s but primary pneumonia rates increased 16% from 2008 to 2011, most notably
among children and young adults. In patients aged 80 years the rate of hospitalizations with
secondary pneumonia more than doubled during the study period. Average 30-day mortality re-
mained stable at 13%, but increased slightly over time in patients aged 80 years.
Conclusions: In an era of smoking cessation and vaccination efforts, pneumonia hospitalization
rates are continuously increasing, largely driven by secondary diagnoses and recurrent pneu-
monia episodes in elderly patients. Thirty-day mortality remains persistently high.
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Pneumonia remains a leading cause of hospitalization
and mortality worldwide [1]. Between the late 1980s and
the mid-2000s, pneumonia-associated hospitalizations
increased by 20e50% in the United States and Europe,
including Denmark [2e6], even after adjusting for popula-
tion ageing [3e6]. These trends appear paradoxical in light
of smoking cessation campaigns and increased uptake of
influenza and pneumococcal vaccinations among high-risk
groups [7,8]. Up-to-date European national data are lack-
ing on nationwide trends in pneumonia rates following
introduction of the 7-valent pneumococcal conjugate vac-
cine (PCV-7) in 2007 and other preventive initiatives in
Europe during the later 2000s [9,10]. Moreover, despite
recent quality improvement strategies and new treatment
guidelines [11], 30-day mortality remains disturbingly high
at 10e15% in population-based studies [4e6].
The major factor driving increasing pneumonia inci-
dence and persistently high mortality may be a growing
prevalence of elderly individuals with chronic diseases
necessitating frequent hospitalizations, use of immuno-
suppressive therapy and surgical interventions [1,2,5,6].
Thus, increasing numbers of recurrent and secondary
pneumonia episodes may be a major contributor to the
pneumonia burden in Western populations. Existing studies
have been hampered by lack of indvidual-level data on
comorbidity and history of hospitalizations, including pre-
vious diagnoses of pneumonia, or by selective inclusion of
hospitals, health insurance systems or age groups [12].
We therefore conducted a 15-year nationwide,
population-based cohort study to examine trends in overall
and first-time pneumonia hospitalization rates by type of
discharge diagnosis, 30-day mortality, and prognostic
impact of age and comorbidity.Methods
Setting
We conducted this cohort study in the entire Danish popu-
lation of 6,850,096 people from 1997 through 2011. The
Danish National Health Service provides universal tax-
supported health care, guaranteeing unfettered access to
general practitioners and hospitals and partial reimburse-
ment for prescribed drugs. Except for emergencies and
severe acute disease, patients’ initial contact with the
healthcare system is through their general practitioner,
who acts as gate-keeper and provides referrals to hospitals
and specialists as necessary. Accurate and unambiguous
linkage of all registries at the individual level is possible in
Denmark by means of the unique personal registry number
assigned to all Danish citizens.
Identification of patients with pneumonia
The Danish National Registry of Patients (DNRP) contains
information on all inpatient hospitalizations at Danish non-
psychiatric hospitals since 1977 and on all emergency room
and hospital outpatient specialist clinic visits since 1995[13]. Each hospital visit is recorded by physicians with one
primary diagnosis and one or more secondary diagnoses
classified according to the International Classification of
Diseases, 8th edition (ICD-8) until the end of 1993, and ICD-
10 thereafter. We used the DNRP to identify all inpatients
with a primary or secondary hospital discharge diagnosis of
pneumonia [ICD-10 codes J12-J18 (pneumonia), A709
(ornithosis), or A481 (legionellosis)] recorded between 1997
and 2011. We classified patients with pneumonia listed as
their primary discharge diagnosis as having primary pneu-
monia, while those with pneumonia listed as a secondary
diagnosis were classified as having pneumonia secondary to
another major condition. Patients who had been hospital-
ized with or without surgery within 30 days prior to the date
of index admission were classified as having secondary
pneumonia regardless of whether they had a primary
diagnosis of pneumonia during the index admission.
Comorbidity data
We computed Charlson Comorbidity Index (CCI) scores for
each patient based on DNRP in-patient hospitalization re-
cords within 10 years preceding the date of pneumonia
diagnosis [14]. We categorized severity of comorbidities as
none (CCI score Z 0), medium (CCI score Z 1e2), or high
(CCI score 3).
Statistical analysis
Hospitalization rates
We computed overall pneumonia hospitalization rates as
the total number of pneumonia-related hospitalization
episodes per year divided by the corresponding mid-year
population (obtained from Statistics Denmark), standard-
ized to the national age and sex distribution in 1997. We
then computed rates of first-time incident pneumonia,
defined as pneumonia in a patient with no prior pneumonia
diagnosis recorded in the DNRP within the preceding 10
years. We stratified rates according to primary pneumonia
and secondary pneumonia and by age group (<5, 5e20,
21e40, 41e64, 65e79, and 80 years). Secondary pneu-
monia were further stratified by the associated primary
discharge diagnosis: cardiovascular disease; chronic lung
disease; cancer; injuries; admission for medical exami-
nation, observation, or rehabilitation; primary septicae-
mia, meningitis, other respiratory tract infection,
unspecified bacterial infection, respiratory failure, or
other respiratory tract symptoms; and other primary
diagnosis codes.
Because secular changes in rates of pneumonia as a
secondary diagnosis may stem from temporal changes in
coding practices, we conducted two sensitivity analyses.
The first addressed whether there was a trend towards
coding more severe cases of pneumonia with alternative
primary diagnoses. To examine this we categorized patients
with a primary diagnosis of sepsis or respiratory failure
combined with a secondary pneumonia diagnosis as having
primary pneumonia. In another sensitivity analysis, we
categorized all secondary pneumonia patients with primary
diagnoses of septicaemia, meningitis, other respiratory
tract infection, unspecified bacterial infection, respiratory
1216 M. Søgaard et al.failure, or other respiratory tract symptoms as having pri-
mary pneumonia. Finally, to compare pneumonia rates with
overall hospitalization trends, we examined age- and sex-
standardized rates of all-cause hospitalizations in Denmark
from 1997 through 2011.
Mortality
For patients with a first-time pneumonia-related hospitali-
zation, we ascertained all-cause mortality from the Danish
Civil Registration System. Follow-up time was computed
from the date of the index hospital admission to the date of
death, emigration, or 30 days following the admission date,
whichever came first. We constructed KaplaneMeier sur-
vival curves to examine crude survival by study period. In
addition, we compared mortality over time using Cox
regression analysis. The 1997e2001 period was used as
reference to estimate 30-day mortality rate ratios (MRRs),
adjusting for sex, age group, and comorbidity. All analyses
were stratified by age, sex, and comorbidity. We also con-
ducted analyses restricted to patients with primary pneu-
monia and analyses restricted to patients with secondary
pneumonia. The proportional hazards assumption was
verified graphically. The Danish Data Protection Agency
approved the study.Results
We identified 552,528 pneumonia-related hospitalizations
in Denmark from 1997 through 2011. Of these, 385,985
(69.9%) were first-time hospitalizations. Of patients with a
first-time pneumonia hospitalization, 59% had primary
pneumonia. Median length of hospital stay for patients with
first-time pneumonia increased from 10 days (interquartile
range (IQR): 4e52) in 1997e2001 to 13 days (IQR: 4e136) in
2007e2011. For those with primary pneumonia, the median
length of stay remained stable at 8.0 days, while for those
with secondary pneumonia it increased from 18 days (IQR:
6e110) in 1997e2001 to 28 days (IQR: 7e211) in 2007e2011.
During the study period, the overall number of hospital
beds in Denmark declined from 4.64 per 1000 population in
1997 to 2.94 in 2011 and the number of beds in medical
wards from 1.94 to 1.21 per 1000 population. Concurrently,
the annual number of hospital bed-days declined from 3.16
per 1000 population in 1997 to 2.10 in 2011 while the annual
rate of all-cause hospitalization in Denmark increased by
13%, from 202 per 1000 population in 1997 to 228 in 2011.Characteristics of patients with a first-time
hospitalization for pneumonia
The proportions of patients with a first-time secondary
pneumonia and patients who had a recent hospitalization or
surgical procedure increased during the study period
(Table 1). The proportion of pneumonia patients with co-
morbidity increased from 42.9% in 1997e2001 to 46.2% in
2007e2011, with increases particularly for cancer (from
7.7% to 10.7%), cerebrovascular disease (from 9.6% to
11.5%), and diabetes (from 7.4% to 10.8%). In contrast,
there was a slight decrease in patients with chronic pul-
monary disease (from 13.8% in 1997e2001 to 12.6% in2007e2011) and chronic heart failure (from 8.0% in
1997e2001 to 7.1% in 2007e2011) (Table 1).Trends in hospitalization rates
Total pneumonia episodes
Fig. 1 shows annual rates of all pneumonia-related hospi-
talizations and first-time hospitalizations for pneumonia.
The age- and sex-standardized annual rate of total
pneumonia-related hospitalizations increased by 63%, from
4.96 hospitalizations per 1000 population in 1997 to 8.09 in
2011. Rates of hospitalizations with primary pneumonia
increased by 44%, from 3.09 hospitalizations per 1000
population in 1997 to 4.46 in 2011 (Fig. 2A, supplementary
Table 1). Over the same period, rates of hospitalizations
with secondary pneumonia increased by 95% (from 1.86 to
6.63 per 1000 population). Most of the total pneumonia
hospitalization increase up to 2005 was attributable to an
82% increase in hospitalizations with secondary pneumonia.
Thereafter, rates of secondary pneumonia remained stable,
while rates of hospitalizations with primary pneumonia
increased by a further 15%. Age-stratified analyses revealed
stable rates of pneumonia among patients <40 years
whereas rates increased by 51% among patients aged 65e79
years and by 91% among those aged 80 years. In children
<5 years, rates per 1000 fell from 12.00 in 2007 (the year of
PCV-7 introduction) to 10.77 in 2009, but then increased
again to 14.09 in 2011 (supplementary Table 2).
When we stratified hospitalizations with secondary
pneumonia by type of primary diagnosis, we observed an
1.7-fold increase in pneumonia coded secondary to septi-
caemia, meningitis, other infections, and other respiratory
tract symptoms, with the rate increasing from 0.68 to 1.86
per 1000 population (Fig. 3). When we re-categorized pa-
tients with a primary diagnosis of sepsis or respiratory tract
infections as having primary pneumonia in the first sensi-
tivity analysis, the increase in secondary pneumonia
decreased from 95% to 80% over time. When we further re-
categorized all patients with primary diagnoses of septi-
caemia, meningitis, unspecified bacterial infection, other
respiratory tract infections, respiratory failure, or other
respiratory tract symptoms as having primary pneumonia in
the second sensitivity analysis, the overall increase in
secondary pneumonia fell to 50%.
First-time pneumonia episodes
Standardized rates of first-time hospitalizations for pneu-
monia per 1000 population increased by 33%, from 3.99 in
1997 to 5.31 in 2011. The rate first increased steadily by 25%
from 3.99 in 1997 to 4.97 in 2005 (Fig. 1, supplementary
Table 1). The rates fluctuated 2005 and 2008 followed by
a 16% increase over the last three years, ending at 5.31 per
1000 population in 2011. Rates of first-time primary pneu-
monia remained relatively stable 1997 through 2008, but
then increased by 24% up to 2011 (Fig. 2B, supplementary
Table 1). Thus, the rate increases up to 2005 were mainly
due to increasing rates of secondary pneumonia. This in-
crease primarily occurred among patients aged 80 years
(supplementary Table 2). In comparison, hospitalization
rates remained relatively stable over time among those
below age 80 years.
Table 1 Characteristics of first-time pneumonia-related hospitalizations in Denmark, 1997e2011.
Study period Difference in proportion
1997e2001 vs. 2007e2011
(95% CI)
1997e2001 2002e2006 2007e2011
no. (%) no. (%) no. (%)
Overall 114,333 (100) 130,547 (100) 141,105 (100) e
Primary pneumonia 71,409 (62.5) 74,435 (57.8) 81,183 (57.5) 4.9 (5.3 to 4.5)
Secondary pneumonia 42,924 (37.5) 55,112 (42.2) 59,922 (42.5) þ4.9 (4.5e5.3)
Hospitalization within 30 days prior
to index admission
14,592 (12.8) 16,843 (12.9) 19,424 (13.8) þ1.0 (0.7e1.3)
Surgical procedure within 30 days prior
to index admission
4467 (3.9) 7189 (5.5) 9291 (6.6) þ2.5 (2.5e2.8)
Sex
Female 54,610 (47.8) 62,601 (48.0) 67,995 (48.2) þ0.4 (0.03e0.8)
Male 59,723 (52.2) 67,946 (52.1) 73,110 (51.8) 0.4 (0.8 to 0.03)
Age group, years
<5 17,733 (15.5) 15,727 (12.1) 17,015 (12.06) 3.2 (3.7 to 3.2)
5e20 3492 (3.1) 3863 (3.0) 4370 (3.1) þ0.04 (0.1e0.2)
21e40 7128 (6.2) 7845 (6.0) 8194 (5.8) 0.4 (0.6 to 0.2)
41e64 21,158 (18.5) 27,389 (21.0) 29,970 (21.2) þ2.7 (2.4e3.0)
65e79 35,154 (30.8) 39,200 (30.0) 41,416(29.4) 1.4 (1.8 to 1.0)
80 and older 29,668 (26.0) 36,523 (28.0) 40,140 (28.5) þ2.5 (2.2e2.8)
Comorbidities included in the Charlson
Comorbidity Index
Previous myocardial infarction 5715 (5.0) 7039 (5.4) 7188 (5.1) þ0.1 (0.1e0.3)
Congestive heart failure 9110 (8.0) 10,585 (8.1) 9994 (7.1) 0.9 (1.1 to 0.7)
Peripheral vascular disease 4504 (3.9) 5605 (4.3) 6184 (4.4) þ0.4 (0.3e0.6)
Cerebrovascular disease 10,918 (9.6) 15,019 (11.5) 16,290 (11.5) þ2.0 (1.8e2.2)
Dementia 2102 (1.8) 3272 (2.5) 3631 (2.6) þ0.7 (0.6e0.8)
Hemiplegia 427 (0.4) 603 (0.5) 728 (0.5) þ0.1 (0.1e0.2)
Chronic pulmonary disease 15,796 (13.8) 17,384 (13.3) 17,838 (12.6) 1.2 (1.4 to 0.9)
Connective tissue disease 3223 (2.8) 3907 (3.0) 3935 (2.8) 0.03 (0.2 to 0.1)
Peptic ulcer disease 5334 (4.7) 5840 (4.5) 5142 (3.6) 1.0 (1.2 to 0.9)
Mild liver disease 1195 (1.1) 1653 (1.3) 1865 (1.3) þ0.3 (0.2e0.4)
Moderate to severe liver disease 343 (0.3) 566 (0.4) 770 (0.6) þ0.2 (0.2e0.3)
Diabetes without end-stage organ damage 5762 (5.0) 7691 (5.9) 9527 (6.8) þ1.7 (1.5e1.9)
Diabetes with end-stage organ damage 2733 (2.4) 4557 (3.5) 5583 (4.0) þ1.6 (1.4e1.7)
Moderate to severe renal disease 2067 (1.8) 3362 (2.6) 4476 (3.2) þ1.4 (1.2e1.5)
Solid cancer 8759 (7.7) 12,879 (9.9) 15,027 (10.7) þ3.0 (2.8e3.2)
Metastatic solid cancer 1057 (0.9) 2325 (1.8) 2721 (1.9) þ1.0 (0.9e1.1)
Leukaemia 796 (0.7) 1046 (0.8) 1127 (0.8) þ0.1 (0.04e0.2)
Lymphoma 1082 (1.0) 1781 (1.4) 1938 (1.4) þ0.4 (0.3e0.5)
AIDS 153 (0.1) 190 (0.2) 183 0.004 (0.03 to 0.02)
Charlson Comorbidity Index score
Low (0) 65,280 (57.1) 69,661 (53.4) 75,971 (53.8) 3.3 (3.6 to 2.9)
Medium (1e2) 36,692 (32.1) 42,999 (32.9) 44,832 (31.8) 0.3 (0.3 to 0.04)
High (>2) 12,361 (10.8) 17,887 (13.7) 20,302 (14.4) þ3.6 (3.3e3.8)
Pneumonia hospitalizations in Denmark 1217Trends in mortality
Overall 30-day mortality in patients with a first-time
pneumonia-related hospitalization remained fairly stable
at 12.4% among patients diagnosed in 1997e2001, 13.1% in
2002e2006, and 13.1% in 2007e2011 (Table 2). After con-
trolling for changes over time in patient age, sex and co-
morbidity, the adjusted 30-day MRR was 0.99 (95% CI:
0.97e1.02) for patients diagnosed in 2002e2006, and 0.99(95% CI: 0.97e1.01) for patients diagnosed in 2007e2011,
compared to 1997e2001. Stratification by age showed a
reduction in relative mortality for patients aged 5e40 years
but the estimates were imprecise, while mortality
remained virtually unchanged in patients above 40 years
(Table 2). Comorbidity-stratified analyses revealed little
change in mortality over time. For patients with primary
pneumonia 30-day mortality improved over time except for
patients 80 years and those with high level of comorbidity
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Figure 1 Age- and sex-standardized hospitalization rates per 1000 population for total pneumonia and first-time pneumonia
hospitalizations in Denmark, 1997e2011.
1218 M. Søgaard et al.for whom mortality remained unchanged (supplementary
Table 3). For secondary pneumonia, mortality remained
persistently high in most age groups.Discussion
This study shows a large and increasing burden of
pneumonia-related hospitalizations. We found a 63% in-
crease in all hospitalizations with pneumonia between 1997
and 2011, including a large increase in secondary pneu-
monia in the elderly. The increase in rates of first-time
pneumonia was less pronounced with stabilization in the
mid-00s, followed by a small increase during the last 3 years
of the study, particularly among children and young adults.
There was little change in average 30-day mortality over
time.
The magnitude of the increase in rates of pneumonia-
related hospitalizations from 1996 through 2005 is consis-
tent with previous European studies [3e5]. The levelling-
off in the mid-2000s may compare to Ruhnke et al.’s find-
ings in the US a few years earlier [6]. In their cohort study of
2.7 million patients aged 65 years with community-
acquired pneumonia, hospitalization rates increasedsteadily starting in 1987, with a peak in 1999, and then
began to decline, except among persons aged 85 years
[6]. In another study, pneumonia-related hospitalization
rates decreased by 26% in adults aged 18e39 years and by
15% in adults aged 65 years after 2002 when PCV7 was
introduced in the US [15]. Recently, Griffin et al. [16]
showed that this decline in the US was sustained during
the decade after PCV-7 introduction, most markedly among
children but also among adults. A third US study reported a
14.7% reduction in the age-standardized hospitalization
rate for lower respiratory tract infections between 1998
and 2006 [17]. In these studies, rates of total versus first-
time pneumonia episodes were not assessed. In contrast
to the declining rates of pneumonia-related hospitalization
in the US, we observed a more substantial and continuous
increase in rates of total pneumonia and in particular in
secondary diagnoses of pneumonia in the elderly. Increas-
ingly frequent hospitalizations for reasons other than
pneumonia may have led to more cases of subsequent
pneumonia. Possible factors also include improved survival
of patients with underlying chronic conditions and more
frequent and aggressive immunosuppressive treatments
that make patients vulnerable to pneumonia. These factors
may also explain the increase in recurrent pneumonias.
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1220 M. Søgaard et al.Still, the rate of all-cause hospitalizations in Denmark
increased much less than pneumonia-related hospitaliza-
tions over the study period. The increase in hospitalizations
for pulmonary infections or respiratory tract symptoms
accompanied by a secondary diagnosis of pneumonia sug-
gests that changes in coding and documentation contrib-
uted to the rise in secondary diagnoses of pneumonia [12].
This may particularly be the case after the introduction of
the diagnosis related group system as a prospective pay-
ment system around year 2000.
The stabilization in rates of first-time hospitalizations
with primary pneumonia from 2005 through 2008 parallels
the reduction in invasive pneumococcal disease the year
after the introduction of PCV7 in the childhood vaccination
program in Denmark [9,18]. The subsequent increase,
particularly in the youngest age groups during 2009e2011,
may relate to emergence of pH1N1 influenza in early 2009
[19,20] and to the epidemic of Mycoplasma pneumonia
infection in Denmark during the autumn and early winter in
both 2010 and 2011 [21]. The general plateau in rates of
first-time pneumonia starting in 2005 preceded both the
2007 introduction of PCV7 and a public smoking ban enac-
ted in August 2007. However, smoking had decreased inDenmark long before [22], and in 2002 the Danish Ministry
for the Interior and Health issued an executive order of free
influenza vaccination for all people aged 65 years [23]. In
the subsequent years this was extended to include other
high-risk groups. From 2002 through 2010 the annual influ-
enza vaccination uptake among people 65 years in
Denmark has been between 47 and 55% with a slightly
increasing trend over time [24].
It is a concern that the crude 30-day mortality remained
practically unchanged between 1997 and 2011. More than
half of pneumonia patients had important preexisting
comorbidities, and 30-day mortality increased sharply with
comorbidity level. Recent population surveillance data
show that prevalence of diabetes and cancer increased in
Denmark during the 2000s, while prevalence of cardiovas-
cular disease and COPD levelled off [25], consistent with
our findings among pneumonia patients. We saw a decline
in comorbidity-adjusted mortality over time only in the
youngest adults, and those aged 65e79 years. In contrast,
we found that the very elderly experienced increasing
pneumonia incidence without mortality reductions e
somewhat in disagreement with previous cohort studies
[2e6,16]. There is a paucity of studies examining time
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Pneumonia hospitalizations in Denmark 1221trends in pneumonia prognosis according to level of co-
morbidity among patients. Our data thus extend previous
research.
Advanced age and comorbidity may influence pneumonia
prognosis in several ways. Less clear-cut presenting symp-
toms in the elderly may lead to delays in diagnosis and
therapy [26e28]. Incident pneumonia may negatively
interact with underlying chronic medical illnesses, such as
chronic obstructive pulmonary disease and chronic heart
disease. In addition, immune dysfunction is common in the
elderly, either as a consequence of comorbid illness or
directly due to ageing [29]. Finally, quality or intensity of
pneumonia care and treatment may be associated with age
and debilitating comorbidity. In a study of 36,516 patients
with community-acquired pneumonia in Alberta, Canada,
Carriere et al. [30] observed that despite an increasing
length of stay with higher age, use of specialized medical
care and hospital costs decreased with age.
Our pneumonia-related hospitalization rates and mor-
tality estimates are based on a nationwide cohort study
conducted in a setting where a national health service
provides unfettered access to health care, thus largely
avoiding referral and diagnostic biases. Nonetheless,
several issues should be considered in interpreting our
results. Some pneumonia coding errors may have occurred.
The predictive value of a hospital diagnosis of pneumonia
in Denmark is high, i.e., 90% [5], similar to other settings,
but might be lower for secondary episodes. We conducted
sensitivity analyses to address concerns about validity of
secondary episodes and changes in coding over time. These
analyses showed that the rising trend for secondary
pneumonia was robust to even major changes in coding
practice. Our study was restricted to inpatients, and up to
80% of pneumonia episodes are treated in primary care
[31]. Increasing hospitalization rates may be explained
partly by general practitioners lowering their threshold
over time for admitting patients with mild pneumonia or
hospitalizing a higher proportion of frail or terminal pa-
tients who previously may have been treated at home.
Still, the median length of stay and the 30-day mortality
rate was virtually constant over the study period, which
probably would not have occurred if the average severity
of hospitalized cases had changed substantially. The higher
mortality reduction over time for primary versus secondary
pneumonia may suggest that increasing pneumonia rates
could be related to more comprehensive coding of sec-
ondary diagnoses.
In conclusion, this study shows a large increase over time
in pneumonia-related hospitalizations in Denmark. Pneu-
monia will continue to have a substantial impact on health
care needs. The short-term prognosis remains virtually
unchanged and unequal improvements in prognosis suggest
that more data are needed on the effectiveness of in-
terventions to reduce mortality among both the very
elderly and patients with co-existing chronic diseases.Competing interests
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